Riverbridge Partners LLC Has $114.72 Million Stock Position in The Ensign Group, Inc. $ENSG

Riverbridge Partners LLC trimmed its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 18.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 569,345 shares of the company’s stock after selling 127,165 shares during the period. The Ensign Group makes up approximately 2.8% of Riverbridge Partners LLC’s holdings, making the stock its 7th biggest holding. Riverbridge Partners LLC’s holdings in The Ensign Group were worth $114,723,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares during the period. Geneos Wealth Management Inc. increased its position in shares of The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of The Ensign Group by 65.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi raised its stake in The Ensign Group by 480,216.7% during the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after buying an additional 57,626 shares during the period. Finally, Brown Advisory Inc. raised its stake in The Ensign Group by 26.1% during the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after buying an additional 421 shares during the period. Institutional investors own 96.12% of the company’s stock.

The Ensign Group Trading Up 1.3%

NASDAQ ENSG opened at $158.89 on Wednesday. The stock has a market capitalization of $9.29 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 1.53 and a beta of 0.68. The stock’s 50 day moving average price is $173.72 and its two-hundred day moving average price is $185.31. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The Ensign Group, Inc. has a 52 week low of $134.79 and a 52 week high of $218.00.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same period last year, the business earned $1.52 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, analysts anticipate that The Ensign Group, Inc. will post 6.82 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. The ex-dividend date is Tuesday, June 30th. This represents a $0.26 annualized dividend and a yield of 0.2%. The Ensign Group’s dividend payout ratio is presently 4.23%.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of The Ensign Group in a research report on Tuesday, June 9th. Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Finally, Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $216.75.

Insiders Place Their Bets

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $196.65, for a total value of $137,655.00. Following the sale, the director directly owned 22,152 shares in the company, valued at approximately $4,356,190.80. The trade was a 3.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction on Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares in the company, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,592 shares of company stock valued at $478,246. 4.00% of the stock is owned by insiders.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.